Article: CHARTER MEDICAL'S CELL-FREEZE APPROVED BY DANA-FARBER.

Charter Medical, Ltd., a division of Lydall, Inc. (NYSE:LDL), has announced that their 501(k) cleared CELL-FREEZE(r) cryogenic storage containers were approved by Dana-Farber Cancer Institute in Boston, MA. CELL-FREEZE(r) was designed for peripherally derived stem cells and used for cryogenic temperature applications as low as -196 degrees Celsius for storage, preservation and transfer. Dana-Farber Cancer Institute, a national leader in adult and pediatric cancer care and research, will be using CELL-FREEZE(r) for stem cell applications.

Peter Ferris, President of Charter Medical, Ltd. states, "We are pleased Dana-Farber Cancer Institute, a world class cancer ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!